Abstract:Severe hearing loss or deafness is often caused by cochlear hair cell loss and can be mitigated by a cochlear implant (CI). CIs target the auditory nerve, consisting of spiral ganglion cells (SGCs), which degenerate gradually, following hair cell loss. In animal models, it has been established that treatment with the neurotrophins brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) reduce SGC degeneration. In this study, we aimed to investigate whether treatment with both BDNF and NT-3 (Cocktail) is superior to treatment with each neurotrophin separately regarding cell preservation and neural responsiveness to electrical stimulation. To this end, deafened guinea pigs received neurotrophic treatment in their right ear via a gelatin sponge on the perforated round window membrane, followed by cochlear implantation 4 weeks later in the same ear for electrophysiological recordings to various stimulation paradigms. Normal-hearing and deafened untreated guinea pigs were included as positive and negative controls, respectively. Substantial SGC loss occurred in all deafened animals. Each of the neurotrophic treatments led to enhanced SGC survival mainly in the basal turn of the cochlea, gradually decreasing toward the apex. The Cocktail treatment resulted in the highest SGC survival in the treated ear, followed by BDNF, with the least protection of SGCs following NT-3 treatment. Survival of the SGC's peripheral processes (PPs) followed the same trend in response to the treatment. However, survival of SGCs and PPs in the contralateral untreated ears was also highest in the Cocktail group. Consequently, analysis of the ratio between the treated and untreated ears showed that the BDNF group, which showed low SGC survival in the untreated ear, had the highest relative SGC survival of the three neurotrophin-treated groups. Neurotrophic treatment had positive effects in part of the electrically evoked compound action-potential recording paradigms. These effects were only observed for the BDNF or Cocktail treatment. We conclude that treatment with either BDNF or a cocktail of BDNF and NT-3 is preferred to NT-3 alone. Furthermore, since the Cocktail treatment resulted in better electrophysiological responsiveness and overall higher SGC survival than BDNF alone, we are inclined to recommend the Cocktail treatment rather than BDNF alone.

Delayed BDNF application in induced deafness in rats

A study of a postauricular approach to rat cochlear scala media lateral wall for microinject lentivirus with EGFP

Study on neural stem cell transplantation into natural rat cochlea via round window.

[Expression of Brain-Derived Neurotrophic Factor Modified Bone Marrow Mesenchymal Stem Cells in the Cochlea of Drug Deafened Guinea Pigs and Its Protection Role].

A Preliminary Study of Brain-Derived Neurotrophic Factor Gene Transfected Bone-Marrow Mesenchymal Stem Cells Transplartafion Damaged Cochlea

Variations of Bdnf and C-Fos and Their Proteins in the Auditory Pathway Induced by Auditory Deprivation and Intracochlear Electrical Stimulation in Infant Rats

Combined brain-derived neurotrophic factor and neurotrophin-3 treatment is preferred over either one separately in the preservation of the auditory nerve in deafened guinea pigs

The Effect of Early Air-Conduction Deprivation on the Postnatal Auditory Development of Rats

BDNF-mediated preservation of spiral ganglion cell peripheral processes and axons in comparison to that of their cell bodies

[Effect of brain-derived neurotrophic factor gene transfected bone-marrow mesenchymal stem cells on damaged cochlear spiral ganglion cells of guinea pigs]

Neuroprotective effects of brain-derived neurotrophic factor (BDNF) on hearing in experimental pneumococcal meningitis.

[Effect of electrical stimulation at auricular points combined with sound masking on the expression of CREB, BDNF and TrkB in the auditory cortex of tinnitus rats]

Brain-derived neurotrophic factor treatment does not improve functional recovery after hair cell regeneration in the pigeon

mTOR Signaling in BDNF-Treated Guinea Pigs after Ototoxic Deafening

Early Auditory Enrichment with Music Enhances Auditory Discrimination Learning and Alters Nr2b Protein Expression in Rat Auditory Cortex

Protective Role of Glial Cell Line-Derived Neurotrophic Factor Following Ototoxic

BDNF-enriched Small Extracellular Vesicles Protect Against Noise-Induced Hearing Loss in Mice.

Chronic neurotrophin delivery promotes ectopic neurite growth from the spiral ganglion of deafened cochleae without compromising the spatial selectivity of cochlear implants

Variation of CREB and NMDAR1 Proteins Induced by Auditory Deprivation and Intracochlear Electrical Stimulation in Infant Rats

Combined AAV-mediated gene replacement therapy improves auditory function in a mouse model of human DFNB42 deafness

Therapeutic Effect of Adeno-Associated Virus (Aav)-Mediated Adnf-9 Expression on Cochlea of Kanamycin-Deafened Guinea Pigs